SummaryGluconeogenesis is a crucial process to support glucose homeostasis when nutritional supply with glucose is insufficient. Because ingested carbohydrates are efficiently fermented to short-chain fatty acids in the rumen, ruminants are required to meet the largest part of their glucose demand by de novo genesis after weaning. The qualitative difference to nonruminant species is that propionate originating from ruminal metabolism is the major substrate for gluconeogenesis. Disposal of propionate into gluconeogenesis via propionyl-CoA carboxylase, methylmalonyl-CoA mutase, and the cytosolic form of phosphoenolpyruvate carboxykinase (PEPCK) has a high metabolic priority and continues even if glucose is exogenously supplied. Gluconeogenesis is regulated at the transcriptional and several posttranscriptional levels and is under hormonal control (primarily insulin, glucagon, and growth hormone). Transcriptional regulation is relevant for regulating precursor entry into gluconeogenesis (propionate, alanine and other amino acids, lactate, and glycerol). Promoters of the bovine pyruvate carboxylase (PC) and PEPCK genes are directly controlled by metabolic products. The final steps decisive for glucose release (fructose 1,6-bisphosphatase and glucose 6-phosphatase) appear to be highly dependent on posttranscriptional regulation according to actual glucose status. Glucogenic precursor entry, together with hepatic glycogen dynamics, is mostly sufficient to meet the needs for hepatic glucose output except in high-producing dairy cows during the transition from the dry period to peak lactation. Lactating cows adapt to the increased glucose requirement for lactose production by mobilization of endogenous glucogenic substrates and increased hepatic PC expression. If these adaptations fail, lipid metabolism may be altered leading to fatty liver and ketosis. Increasing feed intake and provision of glucogenic precursors from the diet are important to ameliorate these disturbances. An improved understanding of the complex mechanisms underlying gluconeogenesis may further improve our options to enhance the postpartum health status of dairy cows.
The objective of this study was to profile phosphoenolpyruvate carboxykinase (PEPCK) and pyruvate carboxylase (PC) mRNA expression in the liver of dairy cattle during the peripartum transition and determine changes in abundance of these mRNA in response to protein fed during the prepartum period. Thirty-eight multiparous Holstein cows were fed diets containing either 12% crude protein (CP) and 26% rumen undegradable protein (RUP), 16% CP and 26% RUP, 16% CP and 33% RUP, or 16% CP and 40% RUP on a dry-matter basis beginning 28 d before expected calving. After calving, all cows were fed a common diet through 56 d in milk (DIM). Northern analysis of RNA from liver biopsy samples obtained on days -28, -14, +1, +28, and +56 relative to calving indicated that PC and PEPCK mRNA expression were responsive to onset of lactation but not to prepartum protein or RUP concentration. Abundance of PEPCK mRNA was similar at -28, -14, and +1 DIM but was elevated by +28 and +56 DIM relative to precalving levels. Liver PC mRNA abundance was elevated on +1 DIM, remained elevated through 28 DIM, and declined to precalving levels by 56 DIM. The activity of PC enzyme was correlated (r2 = 0.89) with PC mRNA abundance. The data demonstrate increased abundance of PC mRNA during the early transition period followed by increased abundance of PEPCK mRNA during the postpartum period and suggest increased potential metabolism of lactate, pyruvate, and amino acids that contribute to the liver pyruvate pool.
Growth of the corn ethanol industry has created a need for alternatives to corn for lactating dairy cows. Concurrent expansion in soydiesel production is expected to increase availability and promote favorable pricing for glycerol, a primary co-product material. The objective of this study was to determine the feeding value of glycerol as a replacement for corn in diets fed to lactating dairy cattle. Sixty lactating Holstein cows housed in individual tie stalls were fed a base diet consisting of corn silage, legume forages, corn grain, soyhulls, roasted soybeans, and protein supplements. After a 2-wk acclimation period, cows were fed diets containing 0, 5, 10, or 15% refined glycerol for 56 d. Cows were milked twice daily and weekly milk samples were collected. Milk production was 36.3, 37.2, 37.9, and 36.2 +/- 1.6 kg/d and feed intake was 23.8, 24.6, 24.8, and 24.0 +/- 0.7 kg/d for 0, 5, 10, and 15% glycerol treatments, respectively, and did not differ except for a modest reduction in feed intake during the first 7 d of the trial for 15% glycerol (treatment x time effect). Milk composition was not altered by glycerol feeding except that milk urea nitrogen was decreased from 12.5 +/- 0.4 to 10.2 +/- 0.4 mg/dL with glycerol addition. Cows fed diets containing 10 and 15% glycerol gained more weight than those fed rations containing 0 or 5% glycerol but body condition scores did not differ with glycerol feeding. The data indicate that glycerol is a suitable replacement for corn grain in diets for lactating dairy cattle and that it may be included in rations to a level of at least 15% of dry matter without adverse effects on milk production or milk composition.
The growing incidence of prediabetes and clinical type 2 diabetes, in part characterised by insulin resistance, is a critical health problem with consequent devastating personal and health-care costs. Vitamin D status, assessed by serum 25-hydroxyvitamin D levels, is inversely associated with diabetes in epidemiological studies. Several clinical intervention studies also support that vitamin D, or its active metabolite 1,25-dihydroxyvitamin D (1,25(OH) 2 D), improves insulin sensitivity, even in subjects with glucose metabolism parameters classified within normal ranges. The mechanisms proposed which may underlie this effect include potential relationships with improvements in lean mass, regulation of insulin release, altered insulin receptor expression and specific effects on insulin action. These actions may be mediated by systemic or local production of 1,25(OH) 2 D or by suppression of parathyroid hormone, which may function to negatively affect insulin sensitivity. Thus, substantial evidence supports a relationship between vitamin D status and insulin sensitivity; however, the underlying mechanisms require further exploration. Vitamin D: Diabetes: Insulin sensitivity: Insulin resistanceThe reported incidence of diabetes is increasing at an alarming rate. The WHO estimates that more than 180 million individuals worldwide have diabetes and that 1·1 million died from diabetes in 2005 (1) . Further, the WHO estimates that this number is likely to more than double by 2030 (1) . The rate of change in incidence of insulin resistance and diabetes cannot be accounted for by shifts in population demographics, which suggests that lifestyle choices, rather than differences in genetics, are a primary contributor. Unfortunately, the dramatic rise in the prevalence of diabetes in this decade is likely to continue given the number of Americans with prediabetes and given that current recommendations for prevention are either ineffective or are not implemented sufficiently.Several lifestyle factors may play a role in this rapid increase in prediabetes and progression to clinical diabetes. An increase in diabetes has occurred concurrently with an increase in obesity, as the latter is a strong risk factor for diabetes. This relationship may be rooted in the general relationship between energy balance, obesity and diabetes. However, the presence, or absence, of specific dietary factors may also play a role in these diseases. Therefore it is critical to identify factors that influence body weight, factors that are independent of weight that will contribute to the prevention of abnormal glucose homeostasis and insulin resistance to reduce the incidence of diabetes beyond the difficult process of weight loss. It has been proposed that vitamin D may play an important role in the development of insulin resistance and diabetes (2 -4) . Although low vitamin D status is also implicated in the development of type 1 diabetes (or insulin-dependent diabetes) diabetes (5) , the present review will focus on the relationship of vitamin D sta...
The objectives of the present study were to determine the effects of rumen undegradable protein (RUP) level of prepartum diets, the supplementation of a rumen-protected choline product, and their interactions on milk production, feed intake, body weight and condition, blood metabolites, and liver triacylglycerides in dairy cows. Rumen-protected choline (RPC) was fed with two levels of RUP to 48 multiparous Holstein cows in a 3 x 2 factorial arrangement of treatments. Beginning 28 d before expected calving, cows were fed 10% rumen degradable protein, either 0, 6, or 12 g/d of RPC as CapShure (Balchem Corp., Slate Hill, NY) and either 4.0 or 6.2% RUP. After calving and through 120 d of lactation, cows received a common diet and continued RPC as per their prepartum assignment. Prepartum dry matter intake (kg/d) was not affected by RPC or RUP. Postpartum intake decreased when 6.2% RUP was fed prepartum. Milk production to 56 d in milk was decreased when cows were fed 6.2% RUP prepartum. Milk protein (kg/d) decreased when additional RUP was fed prepartum. Cows fed RPC lost more weight during the study period and tended to lose more body condition. Plasma urea nitrogen levels in the prepartum period were reduced for cows fed 4.0% RUP prepartum. Mean liver triacylglyceride determined from samples obtained at -28, -14, +1, +28, and +56 d in milk was not affected by RPC, prepartum RUP, or their combinations. Feeding 12 g of RPC/d in conjunction with 4.0% RUP increased milk production, but feeding RPC with 6.2% RUP prepartum and through 56 d in milk decreased production. The data indicate that 6.2% RUP does not benefit close-up dry cows, and the response to RPC depends the RUP content of the prepartum diet.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.